Literature DB >> 34118448

A review of the physiological impact of rare earth elements and their uses in biomedical Mg alloys.

Weijie Weng1, Arne Biesiekierski2, Yuncang Li3, Matthew Dargusch4, Cuie Wen5.   

Abstract

Magnesium (Mg) is well-tolerated by the body, displaying exceedingly low toxicity, rapid excretion, and numerous bioactive effects, including improved bone formation and protection against oxidative stresses; further, Mg alloys can be degraded in vivo to allow complete removal of an implant without surgical intervention, avoiding revision surgery and thrombosis concerns seen with permanent implants. Rare earth elements (REEs) have been of particular interest in alloying Mg alloys for nearly a century due to their unique chemical and physical properties but have attracted increasing attention in recent decades. The REEs contribute greatly to the mechanical and biological properties of metal alloys, and so are common in Mg alloys in a wide variety of applications; in particular, they represent the dominant alloying additions in current, clinically applied Mg alloys. Notably, the use of these elements may assist in the development of advanced Mg alloys for use as biodegradable orthopedic implants and cardiovascular stents. To this end, current research progress in this area, highlighting the physiological impact of REEs in Mg alloys, is reviewed. Clinical work and preclinical data of REE-containing Mg alloys are analyzed. The biological roles of REEs in cellular responses in vivo require further research in the development of biofunctional Mg alloy medical devices. STATEMENT OF SIGNIFICANCE: The presented work is a review into the biological impact and current application of rare-earth elements (REEs) in biodegradable Mg-based biomaterials. Despite their efficacy in improving corrosion, mechanical, and manufacturability properties of Mg alloys, the physiological effects of REEs remain poorly understood. Therefore, the present work was undertaken to both provide guidance in the development of new biomedical alloys, and highlight areas of existing concerns and unclear knowledge. Key findings of this review include a summary of current clinical and preclinical work, and the identification of Sc as the most promising REE with regards to physiological impact. Y, Ce, Pr, Gd, Dy, Yb, Sm, and Eu should be considered carefully before their use as alloying elements, with other REEs intermediate or insufficiently studied.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Biodegradability; Biological impact; Magnesium alloys; Rare earth elements

Mesh:

Substances:

Year:  2021        PMID: 34118448     DOI: 10.1016/j.actbio.2021.06.004

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  4 in total

1.  Effect of Parylene C on the Corrosion Resistance of Bioresorbable Cardiovascular Stents Made of Magnesium Alloy 'Original ZM10'.

Authors:  Makoto Sasaki; Wei Xu; Yuki Koga; Yuki Okazawa; Akira Wada; Ichiro Shimizu; Takuro Niidome
Journal:  Materials (Basel)       Date:  2022-04-26       Impact factor: 3.748

2.  Biodegradable magnesium alloy WE43 porous scaffolds fabricated by laser powder bed fusion for orthopedic applications: Process optimization, in vitro and in vivo investigation.

Authors:  Jinge Liu; Bingchun Liu; Shuyuan Min; Bangzhao Yin; Bo Peng; Zishi Yu; Caimei Wang; Xiaolin Ma; Peng Wen; Yun Tian; Yufeng Zheng
Journal:  Bioact Mater       Date:  2022-02-24

3.  Design of single-phased magnesium alloys with typically high solubility rare earth elements for biomedical applications: Concept and proof.

Authors:  Dong Bian; Xiao Chu; Jin Xiao; Zhipei Tong; He Huang; Qinggong Jia; Jianing Liu; Wenting Li; Hui Yu; Yue He; Limin Ma; Xiaolan Wang; Mei Li; Tao Yang; Wenhan Huang; Chi Zhang; Mengyu Yao; Yu Zhang; Zhigang Xu; Shaokang Guan; Yufeng Zheng
Journal:  Bioact Mater       Date:  2022-10-01

Review 4.  Biodegradable Magnesium Biomaterials-Road to the Clinic.

Authors:  Shukufe Amukarimi; Masoud Mozafari
Journal:  Bioengineering (Basel)       Date:  2022-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.